Detection of genetic alterations in Korean ovarian carcinomas by degenerate oligonucleotide primed polymerase chain reaction-comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 147, Issue 1, 2003, Pages 23-27

  Kim, Gi Jin ^a   Kim, Joo Oh ^b   Hong, Eun Kyung ^c   Kim, Hyun ^a   Chun, Yong Hyuck ^a   Park, Sun Hwa ^a  

^a Korea University College of Medicine   (South Korea)

^b Eulji University   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 16P; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 2Q; CHROMOSOME 3Q; CHROMOSOME 6P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0142248382     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00154-7     Document Type: Article

References (26)

1. Lynch H.T., Casey M.J., Lynch J., White T.E., Godwin A.K. Genetics and ovarian carcinomas. Semin Oncol. 25:1998;265-280.
2. Tanaka K., Boice C.R., Testa J.R. Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet. 43:1989;1-14.
3. Pejovic T., Heim S., Mandahl N., Baldetorp B., Elmfors B., Floderus U.-M., Furgyik S., Heim G., Himmelmann A., Wilen H., Mitelman F. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer. 4:1992;58-68.
4. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., Testa J.R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer. 4:1997;320-328.
5. Suehiro Y., Sakamoto M., Umayahara K., Iwabuchi H., Sakamoto H., Tanaka N., Takeshima N., Yamauchi K., Hasumi K., Akiya T., Sakunaga H., Muroya T., Numa F., Kato H., Tenjin Y., Sugishita T. Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas. Oncology. 59:2000;50-60.
6. Suzuki S., Moore D.H. Jr., Ginzinger D.G., Godfrey T.E., Barclay J., Powell B., Pinkel D., Zaloudek C., Lu K., Mills G., Berchuck A., Gray J.W. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 60:2000;5382-5385.
7. Hauptmann S., Denkert C., Koch I., Petersen S., Schluns K., Reles A., Dietel M., Petersen I. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol. 33:2002;632-641.
8. Launonen V., Mannermaa A., Stenback F., Kosma V.M., Puistola U., Huusko P., Anttila M., Bloigu R., Saarikoski S., Kauppila A., Winqvist R. Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet. 122:2000;49-54.
9. Lassus H., Laitinen M.P., Anttonen M., Heikinheimo M., Asltonen L.A., Ritvos O., Butzow R. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab Invest. 81:2001;517-526.
10. Manderson E.N., Presneau N., Provencher D., Mes-Masson A.M., Tonin R.N. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Mol Carcinog. 34:2002;78-90.
11. Telenius H., Carter N.P., Bebb C.E., Nordenskjold M., Ponder B.A.J., Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics. 13:1992;718-725.
12. Huang Q., Schantz S.P., Rao P.H., Mo J., McCormick S.A., Chaganti R.S.K. Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. Genes Chromosomes Cancer. 28:2000;395-403.
13. Kuukasjävi T., Tanner M., Pennanen S., Karhu R., Visakorpi T., Isola J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer. 18:1997;94-101.
14. Kim GJ, Cho SJ, Won MH, Sung JM, Kim H, Chun YH, Park SH. Genomic imbalances in Korean hepatocellular carcinoma by degenerate oligonucleotide primed PCR-comparative genomic hybridization. Cancer Genet Cytogenet (in press).
15. el-Rifai W., Larramendy M.L., Bjorkqvist A.M., Hemmer S., Knuutila S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest. 77:1997;699-700.
16. Gray J, Daneshvar I, Shoenberg-Fejzo M, Hwang S, Godfrey T, Palazzolo Martin C, Kowbel D, Tanner M, Kallionemi PO, Romments J, Pinkel D, Collins C. Genomic analysis of three regions of increased copy number discovered using CGH. Tucson, AZ: Seventh International Workshop on Chromosomes in Solid Tumors, 1997.
17. Kapeller R., Cantley L.C. Phosphatidylinositol 3-kinase. Bioessays. 16:1994;565-576.
18. Kyo S., Kanaya T., Takakura M., Tanaka M., Yamashita A., Inoue H., Inoue M. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer. 80:1999;804-809.
19. Feldman B.J., Reid T.R., Cleary M.L. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice. Oncogene. 15:1997;2735-2742.
20. Inaba T., Matsushime H., Valentine M., Roussel M.F., Sherr C.J., Look A.T. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics. 13:1992;565-574.
21. Jongsma A.P., Piek J.M., Zweemer R.P., Verheijen R.H., Klein Gebbinck J.W., Van Kamp G.J., Jacobs I.J., Shaw P., Van Diest P.J., Kenemans P. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. Mol Pathol. 55:2002;305-309.
22. Dong J.T., Boyd J.C., Frierson H.F. Jr. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. The Prostate. 49:2001;166-171.
23. Kim H., Lee M.J., Kim M.R., Chung I.P., Kim Y.M., Lee J.Y., Jang J.-J. Expression of cyclin D1, cdk4 loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma. Liver. 201:2000;173-178.
24. Kainu T., Juo S.H., Desper R., Schaffer A.A., Gillanders E., Rozenblum E., Freas-Lutz D., Weaver D., Stephan D., Bailey-Wilson J., Kallioniemi O.P., Tirkkonen M., Syrjakoski K., Kuukasjarvi T., Koivisto P., Karhu R., Holli K., Arason A., Johannesdottir G., Bergthorsson J.T., Johannsdottir H., Egilsson V., Barkardottir R.B., Johannsson O., Haraldsson K., Sandberg T., Holmberg E., Gronberg H., Olsson H., Borg A., Vehmanen P., Eerola H., Heikkila P., Pyrhonen S., Nevanlinna H. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci USA. 97:2000;9603-9608.
25. Imoto I., Pimkhaokham A., Watanabe T., Saito-Ohara F., Soeda E., Inazawa J. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE-super-class, in ovarian cancer cell lines. Biochem Biophys Res Commun. 276:2000;264-270.
26. Anzick S.L., Konomen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.-Y., Sauter G., Kallioneimi O.-P., Trent J.M., Meltzer P.S. AIB1, a novel estrogen receptor co-activator amplified in breast and ovarian cancer. Science. 277:1997;965-968.